Absence Of Btk, Bcl2, And Plcg2 Mutations In Relapsing Chronic Lymphocytic Leukemia (Cll) After First-Line Treatment With Fixed-Duration Ibrutinib (I) Plus Venetoclax (V)
Ibrutinib;Venetoclax
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Absence Of Btk, Bcl2, And Plcg2 Mutations In Relapsing Chronic Lymphocytic Leukemia (Cll) After First-Line Treatment With Fixed-Duration Ibrutinib (I) Plus Venetoclax (V) ### Output: Ibrutinib;Venetoclax